Secure Drug Supply Chain Act of 2026
Key claim: The Secure Drug Supply Chain Act of 2026 (S5043) was introduced in the 119th Congress and referred to the Senate Committee on Health, Education, Labor, and Pensions.
Abstract
(S5043 · 119th Congress) Latest action (2026-07-21): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Why this matters
Drug supply-chain security legislation shapes how the FDA, manufacturers, and distributors prevent and respond to disruptions that can trigger shortages and compounding demand. At introduction with only a referral, the bill has no operative text or immediate effect on what patients pay or what is covered, but its trajectory in the Senate HELP Committee is worth tracking as a potential vehicle for supply-chain rules affecting drug availability.